| scholarly article | Q13442814 |
| P50 | author | Christine Van Broeckhoven | Q2247235 |
| Nathalie Brouwers | Q47910878 | ||
| Sebastiaan Engelborghs | Q56616406 | ||
| Peter Paul De Deyn | Q60327954 | ||
| Karolien Bettens | Q114407921 | ||
| Helen Van Miegroet | Q114407948 | ||
| Kristel Sleegers | Q28480858 | ||
| Jessie Theuns | Q42757468 | ||
| P2860 | cites work | Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease | Q48437807 |
| Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. | Q51922561 | ||
| The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years. | Q53272791 | ||
| Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways | Q57982495 | ||
| Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients | Q24633400 | ||
| Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase | Q24643985 | ||
| The microRNA.org resource: targets and expression | Q24650094 | ||
| microRNA target predictions across seven Drosophila species and comparison to mammalian targets | Q24811535 | ||
| “Mini-mental state” | Q25938989 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| BACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's disease | Q28257726 | ||
| APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy | Q28259007 | ||
| Sequence variants in SLITRK1 are associated with Tourette's syndrome | Q28276961 | ||
| APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy | Q28288090 | ||
| A brain-specific microRNA regulates dendritic spine development | Q29614753 | ||
| Characterization of microRNA expression profiles in normal human tissues | Q29615492 | ||
| The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. | Q33722837 | ||
| Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease | Q34658251 | ||
| Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma | Q34778280 | ||
| Beta-secretase activity increases with aging in human, monkey, and mouse brain. | Q35083409 | ||
| Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects | Q35475856 | ||
| Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease | Q36564159 | ||
| Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression | Q36609033 | ||
| Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease | Q36806008 | ||
| Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. | Q40151267 | ||
| BACE1 gene promoter is differentially regulated: detection of a novel promoter region for its cell type-specific regulation | Q40282792 | ||
| Functional characterization of the 5' flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression | Q40570846 | ||
| A hexanucleotide element directs microRNA nuclear import. | Q41412805 | ||
| MicroRNAs can regulate human APP levels. | Q42426890 | ||
| Gene structure and organization of the human beta-secretase (BACE) promoter. | Q42459613 | ||
| Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease. | Q42664113 | ||
| Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation | Q43565734 | ||
| Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease | Q43783045 | ||
| Set of novel tools for PCR primer design | Q43840649 | ||
| Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease | Q44060098 | ||
| Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease | Q44132132 | ||
| P433 | issue | 8 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 1207-1213 | |
| P577 | publication date | 2009-08-01 | |
| P1433 | published in | Human Mutation | Q5937269 |
| P1476 | title | APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. | |
| P478 | volume | 30 |
| Q36911784 | Abnormal Changes of Brain Cortical Anatomy and the Association with Plasma MicroRNA107 Level in Amnestic Mild Cognitive Impairment |
| Q21202833 | Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function |
| Q53317692 | Amyloid precursor protein gene (APP) variation in late-onset Alzheimer's disease. |
| Q52622902 | Association between BACE1 gene polymorphisms and focal seizures in a Chinese Han population. |
| Q33929052 | Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice |
| Q33871345 | Current status on Alzheimer disease molecular genetics: from past, to present, to future |
| Q34323841 | Epigenetic memory: the Lamarckian brain |
| Q34312041 | Exosome-mediated delivery of siRNA in vitro and in vivo |
| Q43873373 | Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expression |
| Q37642149 | MicroRNA-29a modulates axon branching by targeting doublecortin in primary neurons |
| Q37800789 | MicroRNAs and Their Therapeutic Potential for Human Diseases: Aberrant MicroRNA Expression in Alzheimer’s Disease Brains |
| Q34101214 | MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration |
| Q36602107 | MicroRNAs in age-related diseases |
| Q37946984 | MicroRNAs in neurodegenerative diseases and their therapeutic potential. |
| Q36695844 | Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy |
| Q26859224 | Neuronal dark matter: the emerging role of microRNAs in neurodegeneration |
| Q38051212 | Non-coding RNAs in Alzheimer's disease |
| Q38799079 | Recombinant pre-miR-29b for Alzheimer´s disease therapeutics |
| Q35883202 | Role of common and rare APP DNA sequence variants in Alzheimer disease |
| Q46624520 | The Emerging Role of MitomiRs in the Pathophysiology of Human Disease |
| Q51760979 | The Role of microRNAs in Alzheimer's Disease and Their Therapeutic Potentials. |
| Q33995527 | Understanding microRNAs in neurodegeneration |
| Q50609525 | miR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3. |
Search more.